Keyphrases
Bleeding Time
54%
Platelets
54%
From the Editor
54%
Thrombocytopenia
54%
AIDS/HIV
35%
Platelet-associated IgG
34%
Systemic Lupus Erythematosus
32%
Lupus Anticoagulant
27%
Safe Transfusion
27%
Arteriosclerosis
27%
Unit Identification
27%
Patient Identification Systems
27%
Immune Globulin
27%
Emperipolesis
27%
Blood Units
27%
Transfusion Safety
27%
Burrow
27%
Orthognathic Surgery
27%
Intellectual Property
27%
Titer
27%
Atrial Myxoma
27%
Fragmented Red Cells
27%
Platelet Factors
27%
Anticardiolipin Antibodies
27%
Smooth muscle Cells
27%
Adenylate Kinase
27%
Cell Proliferation
27%
Platelet-derived Growth factor-BB (PDGF-BB)
27%
North Africa
27%
Serum Factors
27%
Southern Europe
27%
Antinuclear Antibodies
27%
Anti-Ro Antibodies
27%
Thrombolytic Therapy
27%
During Pregnancy
27%
Postoperative Hemorrhage
27%
Smooth muscle Cell Proliferation
27%
Anticoagulants
27%
Renal Carcinoma Cells
27%
Natural Killer Cells
27%
Cytotoxicity
27%
Erythropoietin
27%
Human Immunodeficiency Virus Infection
27%
May-Hegglin Anomaly
27%
Renal Vein Thrombosis
27%
Platelet Activity
27%
Southern European
27%
Infants at Risk
27%
Electrophoresis
27%
Schistocytes
27%
Pharmacology, Toxicology and Pharmaceutical Science
Thromboplastin
73%
Disseminated Intravascular Clotting
61%
Heparin
54%
Prothrombin
45%
Bleeding
39%
Blood Clotting Disorder
33%
Disease
32%
Thrombocytopenia
31%
Blood Clotting Factor
30%
Anemia
27%
Adenylate Kinase
27%
Erythropoietin
27%
Ro Antibody
27%
D Dimer
27%
Thrombotic Thrombocytopenic Purpura
27%
Renal Cell Carcinoma
27%
Cardiolipin Antibody
27%
Blood Clotting Inhibitor
27%
Lupus Anticoagulant
27%
May Hegglin Anomaly
27%
Acquired Immune Deficiency Syndrome
27%
Electrophoresis
27%
HIV
27%
Cardiomyopathy
27%
Antinuclear Antibody
27%
Human Immunodeficiency Virus Infection
27%
Systemic Lupus Erythematosus
27%
Chagas Disease
27%
Infection
20%
Fibrinogen
14%
Mouse
13%
Chlordiazepoxide
13%
Chromium 51
13%
Muscle Spasm
13%
Opportunistic Infection
10%
Thrombosis
9%
Sepsis
9%
Normal Human
8%
A J Mouse
6%
Thromboxane B2
6%
Prostaglandin F
6%
Phospholipid
6%
Prostacyclin
6%
Scanning Electron Microscopy
6%
Anticoagulant Agent
6%
Arachidonic Acid
6%
Immunoglobulin
6%
Blood Clotting Factor 5
6%
Adenosine Diphosphate
6%
Warfarin
6%
Medicine and Dentistry
Platelet
100%
Disseminated Intravascular Coagulation
61%
Pediatrics
54%
Bleeding Time
54%
Human Immunodeficiency Virus Infection
54%
Thrombocytopenia
47%
Diagnosis
36%
Human Immunodeficiency Virus
31%
Orthognathic Surgery
27%
Adenylate Kinase
27%
Female Genital Tract Cancer
27%
Atherosclerosis
27%
May Hegglin Anomaly
27%
D-Dimer
27%
Blood Product
27%
Anemia
27%
Macrocytosis
27%
Thrombocyte Adhesion
27%
Prognostic Factor
27%
Bleeding
23%
Schistocyte
21%
Disease
20%
Smooth Muscle Cell
18%
Cell Proliferation
18%
Prothrombin Time
18%
Major Bleeding
11%
Fibrinogen
11%
Patient Population
11%
Injury
11%
Thrombocyte Function
10%
Thrombocyte Factor
9%
Partial Thromboplastin Time
9%
Serum Factor
9%
Renal Vein
9%
Myxoma
9%
Thrombocyte Transfusion
9%
Erythrocyte
9%
Endothelium Injury
9%
Sepsis
9%
Blood Smear
9%
Clinician
9%
Arteriosclerosis
9%
Human Immunodeficiency Virus Antibody
8%
Thrombocyte Concentrate
6%
Dyserythropoiesis
6%
Megaloblastic Anemia
6%
Preoperative Evaluation
5%
Bleeding Disorder
5%
Fibronectin
5%
Patient with Wilms' Tumor
5%
